An ALT-negative/telomerase-positive osteosarcoma cell line (MG63) was also tested—this showed that whilst there was some decreased viability in response to silencing of SOD1, the effect was much milder than that observed in ALT-positive osteosarcomas (Fig. 1C). This evidence concerns the gene SOD1 and osteosarcoma.